Widad inks agreement with Rinani


KUALA LUMPUR: Widad Group Bhd has signed a memorandum of collaboration with Rinani Dynamic Sdn Bhd for the distribution, marketing and selling of the Covid-19 vaccine.

In a statement Tuesday, Widad said Rinani is the local representative in Malaysia for VAXART Inc, an US-based entity that is listed on Nasdaq with respect to its ongoing development of an oral-based (tablet) Covid-19 vaccine.

Subscribe or renew your subscriptions to win prizes worth up to RM68,000!

Monthly Plan

RM13.90/month

Annual Plan

RM12.33/month

Billed as RM148.00/year

1 month

Free Trial

For new subscribers only


Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Widad , Rinani , Vaxart , Covid-19

   

Next In Business News

Trading ideas: PetDag, Atlan, Thong Guan, Maxim, Globetronics, 7-Eleven, Petron, DRB-Hicom, Dayang, MSM, Aeon, SunCon, UEM Sunrise
Oil rises 2% as Russia-Ukraine war escalates
Wall St ends higher as Dow, S&P hit one-week tops
Radium’s net profit up to RM4.8mil in 3Q
7-Eleven’s quarterly revenue climbs
SimeProp seeks quality assets for recurring income
Lower interest costs buoy TSH nine-month showing
Zetrix a profit driver for MyEG Services
NFO segment to sustain Sports Toto’s earnings
Thong Guan spreading its wings to Europe, America

Others Also Read